BCWORLD PHARM. Co., Ltd. (KOSDAQ: 200780)

Market Cap	43.12B
Revenue (ttm)	72.96B
Net Income (ttm)	-6.90B
Shares Out	8.44M
EPS (ttm)	-817.60
PE Ratio	n/a
Forward PE	n/a
Dividend	100.00 (1.96%)
Ex-Dividend Date	n/a

Volume	3
Open	5,120.00
Previous Close	5,090.00
Day's Range	5,120.00 - 5,120.00
52-Week Range	4,770.00 - 7,520.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About BCWORLD PHARM.

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analges...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Employees: 284
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200780

Financial Performance

In 2023, BCWORLD PHARM.'s revenue was 75.11 billion, an increase of 3.31% compared to the previous year's 72.70 billion. Earnings were 2.63 billion, an increase of 836.31%.